Please ensure Javascript is enabled for purposes of website accessibility

Why Quest Diagnostics Stock Jumped Today

By Keith Speights - Apr 23, 2019 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A positive Q1 update provided a nice boost to the diagnostics information services stock.

What happened

Shares of Quest Diagnostics (DGX 3.79%) were 9.9% higher as of 3:36 p.m. EDT on Tuesday. The diagnostic information services company announced better-than-expected first-quarter results before the market opened.

Quest reported Q1 revenue of $1.89 billion, higher than the consensus analysts' estimate of $1.87 billion. The company's Q1 adjusted EPS came in at $1.40, above the consensus estimate of $1.36.

Businessman looking at a line chart going up

Image source: Getty Images.

So what

In the big scheme of things, one good quarter doesn't necessarily mean a whole lot. But it's definitely a positive sign for Quest Diagnostics' underlying business that the company got off to a good start in 2019.

CFO Mark Guinan didn't sound overly confident about the company's Q1 prospects in the fourth-quarter conference call in February. He noted that Quest would incur extra costs in Q1 related to its expanded network access and would have one less revenue day in the quarter. Because of these and other factors, Guinan thought that Q1 revenue would be flat to down, with adjusted EPS similar to its Q4 result.

That turned out to be too pessimistic. CEO Steve Rusckowski stated in the Q1 press release that the company anticipated higher volumes in Q1. That expectation was met and then some. And while Quest continues to face reimbursement pressures, the company's efforts to increase productivity appear to be working.

Now what

Quest confirmed its previous full-year 2019 outlook. The company still expects net revenue between $7.6 billion and $7.75 billion with adjusted EPS greater than $6.40. The big thing for investors to watch now is its inclusion into UnitedHealth Group's Preferred Lab Network effective July 1, 2019. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Quest Diagnostics Incorporated Stock Quote
Quest Diagnostics Incorporated
$140.52 (3.79%) $5.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.